e-learning
resources
London 2016
Wednesday, 07.09.2016
Lung cancer: therapeutic modalities, re-staging, and follow-up
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
What predicts radiation pneumonitis best? Pulmonary injury after curatively intended radiotherapy of early-stage lung cancer
Janna Berg (Porsgrunn, Norway), Janna Berg, May-Bente Bengtson, Odd Terje Brustugun, Åslaug Helland
Source:
International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Session:
Lung cancer: therapeutic modalities, re-staging, and follow-up
Session type:
Poster Discussion
Number:
4846
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Janna Berg (Porsgrunn, Norway), Janna Berg, May-Bente Bengtson, Odd Terje Brustugun, Åslaug Helland. What predicts radiation pneumonitis best? Pulmonary injury after curatively intended radiotherapy of early-stage lung cancer. Eur Respir J 2016; 48: Suppl. 60, 4846
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: What’s NEW in the 2022 ERS/ATS PFT Interpretation Statement
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Our results of stereotactic radiotherapy in advanced stage lung cancer patients
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014
Mode of influence of pulmonary rehabilitation to lung function changes after the lung resection for primary lung cancer
Source: Annual Congress 2013 –Lung surgery: preoperative assessment and postoperative outcome
Year: 2013
Lung function in the elderly patients with a diagnosis of lung cancer - A challenge for the surgical treatment?
Source: International Congress 2015 – Surgery and lung cancer: results and complications
Year: 2015
Stereotactic body radiation does not impair respiratory health in patients with stage I non-small cell lung cancer
Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts
Year: 2013
Is there a change in pulmonary function in patients with COPD and primary lung cancer treated with radiofrequency ablation (RFA)?
Source: International Congress 2014 – Advances in diagnosis and therapy of thoracic tumours
Year: 2014
Stereotactic ablative radiotherapy (SABR) in non-surgical non small cell lung cancer: Effects on respiratory function
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014
Lung function estimation in patients with lung cancer qualified for surgical treatment
Source: Eur Respir J 2006; 28: Suppl. 50, 719s
Year: 2006
Lung function assessment in octogenarians with lung cancer diagnosis
Source: International Congress 2017 – Thoracic surgery
Year: 2017
Surfactant protein-D level as a predictor of prognosis of interstitial lung disease induced by anticancer agents in advanced lung cancer
Source: International Congress 2016 – Orphan diseases I
Year: 2016
Possible indication for surgical resection of lung cancer associated with combined pulmonary fibrosis and emphysema (CPFE)
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013
Does consolidation chemotherapy improves survival for locally advanced non-small-cell lung cancer patients receiving concurrent chemoradiotherapy?
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016
The impact of pulmonary rehabilitation on preoperative inflammatory markers in lung cancer patients
Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts
Year: 2013
Lung function predicts lung cancer
Source: Eur Respir J 2010; 35: 1421-1422
Year: 2010
Incidence of interstitial lung disease (ILD) and risk factors for developing ILD: A final analysis of a large-scale erlotinib Japanese surveillance study in non-small-cell lung cancer (NSCLC)
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
Survival in elderly patients undergoing lung resection for lung cancer
Source: International Congress 2015 – Lung cancer therapy: clinical trials
Year: 2015
Pulmonary function during lung cancer therapy: A retrospective analysis of patients treated with monotherapy or multimodal treatments
Source: International Congress 2016 – Clinical aspects of lung cancer
Year: 2016
Completion pneumonectomy for lung cancer relapse after surgery- What is a real benefit?
Source: International Congress 2016 – Special issues in thoracic surgery
Year: 2016
Outcomes of pulmonary rehabilitation after lung resection in patients with lung cancer
Source: Virtual Congress 2021 – Pulmonary rehabilitation in clinical conditions
Year: 2021
Lung cancer tissue diagnosis in poor lung function: Addressing the ongoing percutaneous lung biopsy FEV1 paradox using Heimlich valve
Source: International Congress 2016 – Clinical aspects of lung cancer
Year: 2016
Advanced lung cancer inflammation index (ALI): A new pronostic score in patients with non small cell lung cancer
Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept